Cambrex announces 10,000 sq ft stability storage expansion in Waterford
Cambrex today announced the expansion of their stability storage business, Q1 Scientific, through adding 10,000 sq ft at their existing facility in Waterford, Ireland. Q1 Scientific offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. The development at Waterford is coupled with the opening of a new 20,000 sq ft cGMP facility in Belgium, both expansions will be completed in the first half of 2023.
Q1 Scientific’s Waterford-based facility has doubled in size over the past two years and continues to grow with this new 10,000 sq ft expansion. Stephen Delaney, Managing Director of Q1 Scientific said:
“With Cambrex’s scientific expertise and scale, we are able to accelerate our growth plans and launch a second site in 2023,”
“Operating two sites will be a great benefit to our European customers, who can now expect even faster turnaround times for the return of samples. Meanwhile, we will also be able to provide greater temperature-controlled transport options in mainland Europe.”
Tom Loewald, CEO at Cambrex says,
“We are delighted to expand the Q1 Scientific business into Belgium, where we will be able to serve pharmaceutical companies across Germany, France, and the Netherlands. Simultaneously, we will continue to expand our Waterford facility to meet the demand within the Irish market.”
Cambrex continues to expand its capabilities and capacity across its North American and European network to meet the growing demand for outsourced drug development and manufacturing services.
About Q1 Scientific, a Cambrex company
Q1 Scientific, a Cambrex company, was founded in Waterford, Ireland in 2013 by Louise Grubb, and offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries at their 20,000 sq ft. cGMP facility. As the first company in the sector to establish in Ireland, Q1 Scientific is revolutionising the way pharmaceutical companies store their products, helping to improve the speed it takes for new drugs to reach the marketplace along with saving companies the expense of building and monitoring their own storage chambers. In June 2022, Q1 Scientific was acquired by US company Cambrex.
Q1 Scientific are hosting a Stability Studies conference on Thursday 13th October 2022 at the Killashee Hotel, Naas. To find out more about this event, please visit: conference website.
